- Home
- MLYS vs KIDS Comparison
MLYS vs KIDS Comparison
Compare MLYS & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- KIDS
- Stock Information
- Founded
- MLYS 2019
- KIDS 2007
- Country
- MLYS United States
- KIDS United States
- Employees
- MLYS N/A
- KIDS N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- KIDS Medical/Dental Instruments
- Sector
- MLYS Health Care
- KIDS Health Care
- Exchange
- MLYS Nasdaq
- KIDS Nasdaq
- Market Cap
- MLYS 634.6M
- KIDS 657.7M
- IPO Year
- MLYS 2023
- KIDS 2017
- Fundamental
- Price
- MLYS $9.97
- KIDS $26.39
- Analyst Decision
- MLYS Strong Buy
- KIDS Buy
- Analyst Count
- MLYS 2
- KIDS 7
- Target Price
- MLYS $30.00
- KIDS $36.71
- AVG Volume (30 Days)
- MLYS 250.2K
- KIDS 303.5K
- Earning Date
- MLYS 03-20-2025
- KIDS 03-05-2025
- Dividend Yield
- MLYS N/A
- KIDS N/A
- EPS Growth
- MLYS N/A
- KIDS N/A
- EPS
- MLYS N/A
- KIDS N/A
- Revenue
- MLYS N/A
- KIDS $189,673,000.00
- Revenue This Year
- MLYS N/A
- KIDS $39.26
- Revenue Next Year
- MLYS N/A
- KIDS $18.08
- P/E Ratio
- MLYS N/A
- KIDS N/A
- Revenue Growth
- MLYS N/A
- KIDS 33.47
- 52 Week Low
- MLYS $8.58
- KIDS $21.02
- 52 Week High
- MLYS $16.91
- KIDS $35.99
- Technical
- Relative Strength Index (RSI)
- MLYS 40.13
- KIDS 59.96
- Support Level
- MLYS $9.18
- KIDS $26.29
- Resistance Level
- MLYS $10.71
- KIDS $27.60
- Average True Range (ATR)
- MLYS 0.84
- KIDS 1.38
- MACD
- MLYS -0.05
- KIDS 0.34
- Stochastic Oscillator
- MLYS 28.72
- KIDS 76.09
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.